Create Alert
Watchlist

Glenmark Pharmaceuticals

₹2,026.10
+9.30 (0.46%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
2,016.80
Prev. Close
2,016.80
Volume
2,13,335
Total traded value
43.22 Cr
Upper Circuit
2,218.40
Lower Circuit
1,815.20

Fundamentals

Market Cap₹56,957Cr
ROE14.89%
P/E Ratio(TTM)75.56
EPS(TTM)26.71
P/B Ratio6.44
Dividend Yield0.12%
Industry P/E35.33
Book Value313.59
Debt to Equity0.28
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Glenmark Pharma

Glenmark is a research-focused global pharmaceutical company making affordable medicines in areas like respiratory, dermatology, and oncology, including well-known brands like Candid and Ascoril. The company's core mission is to make quality healthcare more accessible to people around the world by focusing on continuous innovation and new treatments. It has a significant global commercial presence, with operations in over 80 countries worldwide.;
Parent OrganisationGlenmark Pharmaceuticals Limited
Managing DirectorMr. Glenn Saldanha
NSE SymbolGLENMARK

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
46.65%
Foreign Institutions
20.62%
Mutual Funds
15.55%
Retail And Others
15.09%
Other Domestic Institutions
2.09%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
37.73
Cipla
NA
(0.00%)
22.89
Dr Reddy's Laboratories
NA
(0.00%)
19.22
Mankind Pharma
NA
(0.00%)
55.88